The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
xin xing kou fu di san dai tou zuo jun su ceftibuten
Author(s): 
Pages: 371-372
Year: Issue:  6
Journal: World Clinical Drugs

Keyword:  第三代头孢菌素Ceftibuten头孢呋肟体外抗菌活性头孢克罗奈瑟氏菌克雷志贺氏菌属头孢特仑革兰氏阴性杆菌;
Abstract: <正> Ceftibuten是日本盐野义株式会社(代号为7432-s)和美国先令公司(代号为sch39720)同时独立开发的一个新型口服第三代头孢菌素,其结构为: 一、体外抗菌活性采用7000多株临床分离细菌对Ceftibuten进行体外抗菌活性的测定结果表明:本品对奈瑟氏菌属活性最优,超过了头孢呋肟、头孢克罗、头孢克肟、头孢特仑等抗生素,对大肠杆菌、克雷白氏肺炎杆菌、吲哚阴性和吲哚阳性变形杆菌、沙门氏菌、志贺氏菌属、普鲁威登斯菌属及柠檬杆菌等具有很强的抗菌活
Related Articles
No related articles found